AKT1 and non-small cell lung carcinoma: Luteolin-induced EGFR degradation is attributed to its inhibition of Hsp90 binding to the mutant EGF receptor, thus disrupting PI3K/Akt/mTOR pathway signaling, which ultimately leads to apoptosis of NSCLC cells.